USFDA issues 13 observations after inspection of Lupin arm's Somerset facility

USFDA issues 13 observations after inspection of Lupin arm's Somerset facility

Drug firm Lupin on Monday said the US health regulator has issued 13 observations after inspection of its subsidiary''s Somerset facility in New Jersey.